Corcept Therapeutics, Inc. (CORT)
83.40
+0.25
(+0.30%)
USD |
NASDAQ |
Dec 10, 11:10
Corcept Therapeutics Total Assets (Quarterly): 823.61M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Gilead Sciences, Inc. | 58.53B |
| LeMaitre Vascular, Inc. | 598.07M |
| United Therapeutics Corp. | 7.351B |
| Vertex Pharmaceuticals, Inc. | 24.86B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 191.70M |
| Shareholders Equity (Quarterly) | 631.90M |
| Debt to Equity Ratio | 0.0101 |
| Current Ratio | 3.141 |
| Net Debt Paydown Yield | -0.00% |